- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Sympathetic ophthalmia.
Displaying page 1 of 1.
EudraCT Number: 2013-004973-29 | Sponsor Protocol Number: CL3-78989-019 | Start Date*: 2014-08-13 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A safety open-label study of Gevokizumab in the treatment of patients with chronic non-infectious Uveitis disease, an eXtension study. The EYEGUARD-X study. | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: chronic non-infectious uveitis | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) IT (Completed) PT (Completed) ES (Completed) AT (Completed) GR (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001610-42 | Sponsor Protocol Number: X052130/CL3-78989-005 | Start Date*: 2013-01-24 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:XOMA (US) LLC | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Non-infectious Intermediate, Posterior, or Pan- Uveitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) PT (Completed) GB (Prematurely Ended) ES (Completed) GR (Prematurely Ended) AT (Completed) PL (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001609-25 | Sponsor Protocol Number: X052131/CL3-78989-006 | Start Date*: 2013-01-02 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:XOMA (US) LLC | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A RandomizEd, Double-masked, Placebo-controlled Study of the SafetY and Efficacy of GevokizUmAb in the TReatment of Subjects with Non-infectious IntermeDiate, Posterior, or Pan- uveitis Currently C... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Non-infectious Intermediate, Posterior, or Pan- Uveitis | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) PT (Completed) IT (Completed) GR (Prematurely Ended) ES (Completed) PL (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006545-13 | Sponsor Protocol Number: LX211-03-UV | Start Date*: 2007-04-27 | |||||||||||
Sponsor Name:Lux Biosciences GmbH | |||||||||||||
Full Title: A Double-Masked, Placebo-Controlled, Multi-Centre, Dose-Ranging Study to Assess the Efficacy and Safety of LX211 as Therapy in Subjects with Active Sight Threatening, Non-Infectious Uveitis. | |||||||||||||
Medical condition: Subjects with active sight-threatening, non-infectious anterior, anterior and intermediate- or panuveitis who require systemic immunosuppression for the control of their disease. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) GB (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004709-24 | Sponsor Protocol Number: CERL080ANL05 | Start Date*: 2007-03-20 | |||||||||||
Sponsor Name:ErasmusMC | |||||||||||||
Full Title: Mycophenolate sodium (Myfortic®) in the Treatment of Uveitis: a Pilot Study. | |||||||||||||
Medical condition: Uveitis | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006543-31 | Sponsor Protocol Number: LX211-01-UV | Start Date*: 2007-04-13 | |||||||||||
Sponsor Name:Lux Biosciences GmbH | |||||||||||||
Full Title: A Double-Masked, Placebo-Controlled, Parallel-Group, Multi-Center, Dose-Ranging Study with an Optional Extension to Assess the Efficacy and Safety of LX211 as Therapy in Subjects with Active Sight ... | |||||||||||||
Medical condition: Subjects with active sight-threatening, non-infectious intermediate-, anterior and intermediate-, posterior- or pan-uveitis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) GB (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006544-66 | Sponsor Protocol Number: LX211-02-UV | Start Date*: 2007-04-13 | |||||||||||
Sponsor Name:Lux Biosciences GmbH | |||||||||||||
Full Title: A Double-Masked, Placebo-Controlled, Parallel-Group, Multi-Centre, Dose-Ranging Study with an Optional Extension to Assess the Efficacy and Safety of LX211 as Therapy in Subjects with Clinically Qu... | |||||||||||||
Medical condition: Subjects with clinically quiescent sight-threatening, non-infectious intermediate-, anterior and intermediate-, posterior- or pan-uveitis requiring systemic immune suppression. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) GB (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
